The reason for this is unclear, but it may be due to the fact that in SCLC, PD-L1 is predominantly expressed on the surface of tumor-infiltrating immune cells rather than on the surface of tumor cells, which can independently attenuate anti-cancer immunity (30, 31). This evidence concerns the gene CD274 and cancer.